Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Non-Current Deffered Revenue (2016 - 2025)

Historic Non-Current Deffered Revenue for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $49.8 million.

  • Cryo Cell International's Non-Current Deffered Revenue rose 1027.65% to $49.8 million in Q3 2025 from the same period last year, while for Aug 2025 it was $49.8 million, marking a year-over-year increase of 1027.65%. This contributed to the annual value of $46.6 million for FY2024, which is 1303.86% up from last year.
  • Cryo Cell International's Non-Current Deffered Revenue amounted to $49.8 million in Q3 2025, which was up 1027.65% from $48.8 million recorded in Q2 2025.
  • Over the past 5 years, Cryo Cell International's Non-Current Deffered Revenue peaked at $49.8 million during Q3 2025, and registered a low of $28.0 million during Q1 2021.
  • Over the past 5 years, Cryo Cell International's median Non-Current Deffered Revenue value was $38.7 million (recorded in 2023), while the average stood at $38.8 million.
  • Per our database at Business Quant, Cryo Cell International's Non-Current Deffered Revenue surged by 1600.76% in 2021 and then soared by 1027.65% in 2025.
  • Cryo Cell International's Non-Current Deffered Revenue (Quarter) stood at $31.3 million in 2021, then grew by 15.11% to $36.0 million in 2022, then increased by 14.41% to $41.2 million in 2023, then rose by 13.04% to $46.6 million in 2024, then rose by 7.06% to $49.8 million in 2025.
  • Its Non-Current Deffered Revenue was $49.8 million in Q3 2025, compared to $48.8 million in Q2 2025 and $47.7 million in Q1 2025.